Summary
Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Pancreatic Cancer in 17 Major Markets
Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of the disease. The prognosis of pancreatic cancer, especially for later stages, is quite poor and has the lowest survival rate of all cancers.
This report provides the current incidence population for Pancreatic Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Canada, Australia, South Africa, Saudi Arabia, Argentina, and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, locations and histopathology of Pancreatic Cancer tumours. These sub-populations within the main disease are included at a country level across a 10-year forecast snapshot.
Main symptoms and co-morbidities for Pancreatic Cancer include:
• Obesity
• Diabetes
• Jaundice
• Pancreatitis
• Gallbladder enlargement
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Pancreatic Cancer’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the incidence of the subdivided types of Pancreatic Cancer and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Identify sub-populations within Pancreatic Cancer which require treatment.
• Gain an understanding of the specific markets that have the largest number of Pancreatic Cancer patients.
'
Table of Contents
• List of Tables and Figures
• Introduction
• Cause of the Disease
• Risk Factors & Prevention
• Diagnosis of the Disease
• Variation by Geography/Ethnicity
• Disease Prognosis & Clinical Course
• Key Co-morbid Conditions/ Features Associated with the Disease
• Methodology for Quantification of Patient Numbers
• Top-Line Incidence for Pancreatic Cancer
• Stages and Location of Pancreatic Cancer
o Staging of Pancreatic Cancer
o Histopathology of Pancreatic Cancer
o Pancreatic Cancer Tumour Location
• Abbreviations used in the Report
• Other Black Swan Analysis Publications
• Black Swan Analysis Online Patient-Based Databases
• Patient-Based Offering
• Online Pricing Data and Platforms
• References
• Appendix
List of Tables
• AJCC Tumour Staging Classification for Pancreatic Cancer
• Incidence of Pancreatic Cancer, total (000s)
• Incidence of Pancreatic Cancer, males (000s)
• Incidence of Pancreatic Cancer, females (000s)
• AJCC Stages of Pancreatic Cancer patients, total (000s)
• Major Histopathological type in Pancreatic Cancer, total (000s)
• Tumour location in Pancreatic Cancer patients, total (000s)
• Abbreviations and Acronyms used in the report
• USA Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• USA Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• France Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• France Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Germany Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Germany Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Italy Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Italy Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Spain Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Spain Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• UK Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• UK Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Brazil Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Brazil Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Japan Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Japan Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• India Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• India Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Australia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Australia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Canada Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Canada Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Mexico Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Mexico Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Turkey Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Turkey Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• South Africa Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• South Africa Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Saudi Arabia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Saudi Arabia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Argentina Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Argentina Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
• Russia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
• Russia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
